Showing posts with label HGH. Show all posts
Showing posts with label HGH. Show all posts

Apr 22, 2014

Human Growth Hormone (HGH) and Insulin-Like Growth Factor 1


Restoring Growth Hormone

It has been argued that the age-dependent decline in sex steroid, Growth Hormone, and IGF-I production is nature’s way of protecting us from cancer and heart disease, but a far more likely scenario is that once we reach our reproductive capacity, nature begins programming us for death.

Such programming begins as the second decade of life draws to a close, the negative consequences of which become more noticeable with each passing year.  We begin to experience a steady decline in immune function. Our bodies increase production of glucocorticoids (catabolic hormones) and cytokines (inflammatory) which negatively impact metabolism, bone density, strength, exercise tolerance, cognitive function, and mood.

The hormones of sex, dehydroepiandrosterone (DHEA), Human Growth Hormone (HGH), and Insulin-like Growth Factor (IGF-1) are positively correlated with the health and well-being of the body in general and the specific functioning of metabolism, the cardiovascular system, the musculature skeletal system, cognitive function & the immune system. However these hormonal levels naturally decline as we age and as a consequence those systems necessary to maintain optimal health decline as well.

A progressive decline in lean body mass, atrophy of its component organs & reduction in their function and increased deposition of adipose tissue mass characteristic of the aging human body result partially from the body's diminished secretion of HGH. These negative changes resulting from growth hormone deficiency have been shown to be reversible by replacement doses of HGH.

HGH is a vital anabolic hormone whose positive stimulatory effects on protein synthesis (particularly in the liver, muscle, bone, cartlidge, spleen, kidney, skin, thymus, and red blood cells) and on lipolysis (the breakdown of fat stored in fat cells) contributes greatly to growth, repair & well-being.

HGH secretion is primarily regulated by the release of two peptides, Growth Hormone-Releasing Hormone (GHRH) and Somatostatin. The hypothalamus region of the brain releases these hormones in response to signals from the central nervous system. GHRH once released makes its way to the receptors on the somatotrope cells of the pituitary gland of the brain where it stimulates HGH release. Somatostatin once released makes its way to the receptors on the somatotrope cells of the pituitary gland of the brain where it inhibits HGH release.

The primary physiological action of somatostatin is to inhibit synthesis and release of GH.  The primary physiological action of Growth Hormone-Releasing Hormone (GHRH) is to stimulate synthesis and release of HGH. The end product of this cascade, HGH once secreted exerts its effect in the body as a whole both directly and indirectly through its initiation of Insulin-like Growth Factor (IGF-1) synthesis in the liver. IGF-1 in turn exerts its effect in the body and its rise in turn begins to inhibit any further HGH release.

HGH is released periodically within the body in a controlled pulsating fashion. This periodic pattern plays an important role in transmitting the HGH "growth, repair & well-being" message to tissue. A review of several studies involving HGH replacement in HGH-deficient animals reveals the biological significance of episodic secretion. These studies conclude that HGH released in a pulsatile pattern is far more efficient in improving mammalian growth and repair than the method of HGH administration by constant infusion.

In males HGH pulses occur approximately every three (3) hours, a frequency that appears across most mammals. The secretion bursts are preceded and followed by almost undetectable levels of plasma HGH. In females however HGH pulses occur more frequently and the base level of plasma HGH remains higher than males who have fewer HGH pulses but the amplitude of which are more pronounced.  HGH pulse amplitudes are increased during slow wave sleep such that particularly in males, most HGH secretion occurs at night. HGH secretion is highest during the growing years of youth and early adulthood. In humans the secretion rate starts to noticeably decrease during the third decade of life and strongly decreases during the fourth decade of life. As we age the daytime secretory pulses diminish first, while the sleep associated HGH pulse persists and diminishes gradually.

Nudging Nature

HGH levels may be increased either by exogenically administering HGH or by administering Growth Hormone-Releasing Hormone which then endogenically stimulates the somatrope cells of the pituitary to secrete additional HGH. The primary advantage of GHRH is that HGH ends up being released in physiological conformance to the body’s natural biorhythm. This biorhythm is pulsatile.

Studies have concluded that endogenous Growth Hormone Releasing Hormone (GHRH) is the principal regulator of pulsatile HGH secretion in humans and that continuous GHRH infusion augments pulsatile HGH release. Whereas exogenic administration of HGH raises overall HGH levels but has no effect on amplifying the pulses.

People of all ages naturally continue to possess the ability to secrete HGH from stores within the pituitary. Most studies are in agreement on this point. One study in particular examined the effects of administration of GHRH & a Growth Hormone Releasing Peptide on all adult age groups from those in their 20's to those above 75 years of age. They observed substantial increases in HGH release as a direct result of administration of GHRH & GHRP-6. This prompted them to conclude, "...that the lack of side-effects & safety of the protocol and the discovered lack of age-related decline in the 'GHRH-GHRP-6-mediated' GH release opens the possibility of using it as a therapeutical tool to revert some deleterious manifestations of aging in man."

Feb 28, 2014

Human Growth Hormone: Everything You Need to Know About HGH


Human growth hormone can turn back your body’s internal clock, helping you rapidly build muscle, slash fat, and increase libido, all while sending energy levels through the roof, but when it comes to discussions on HGH, there are often more questions than answers.

The body naturally produces growth hormone in the pituitary gland, and, as its name implies, it is responsible for cell growth and regeneration. Increasing muscle mass and bone density are impossible without HGH, but it also plays a major role in maintaining the health of all human tissue, including that of the brain and other vital organs. When secreted, HGH remains active in the bloodstream for only a few minutes, but this is enough time for the liver to convert it into growth factors, the most crucial of which is insulin-like growth factor-1, or IGF-1, which boasts a host of anabolic properties. Scientists began to harvest HGH from the pituitary glands of cadavers in the 1950s, but didn’t synthesize the first HGH in laboratories until 1981, with its use as a performance-enhancing drug becoming popular shortly thereafter. Healthy adult men typically have just less than 5 nanograms per milliliter circulating in the blood. Healthy females can produce about twice that amount for child-bearing purposes. Levels for both sexes peak during puberty and drop sharply starting in the early 20s.

Remember when creatine was billed by the mainstream media as potentially dangerous? Now it’s the most heavily researched supplement in the world, and studies bear out the fact that it’s one of the safest and most effective supplements you can take. Medical professionals say that the dangers surrounding HGH are similarly overblown. “Complications [with HGH use] are very minimal,” says Eric Braverman, M.D., who specializes in anti-aging at Path Medical Center in New York City. “Some people experience fluid retention, and a blood sugar rise, but even these are very rare un- less you take a lot. Only a few people ever come in with big feet or big livers—from mega-doses—and they weren’t my patients. It’s very rare.”

Aside from HGH’s crucial role in building muscle mass, not all of its benefits are necessarily evident to the naked eye. HGH has been shown to slow the progression of age-related degenerative diseases, as well as increase sex drive, help maintain mental acuity, and engender a general sense of well-being. The flip side of the coin - low HGH - can result in the exact opposite: muscle loss, fat gain, low sex drive and energy levels, and a poor sense of well-being.

Two major factors that contribute to increased HGH levels are ones you can control without drugs: weight training and proper sleep. The more you exercise, the more HGH you release naturally. A recent study observed significant increases in circulating HGH and IGF-1 after intense resistance exercise in a group of trained men, but found no significant diferences in untrained men who performed the same workout. HGH is also secreted while you sleep, and studies have shown a spike in HGH levels at the onset of deep sleep, so getting the recommended seven to nine hours per night is essential to maintaining HGH. Diet is the third major factor in keeping HGH levels topped of.

Feb 19, 2014

Human Chorionic Gonadotropin (HCG) and Post Cycle Therapy (PCT)


Ideally, HCG should not be used at all in PCT. For steroid cycles, HCG really should only be used in PCT if a mistake has been made which needs a correction.
When it’s used in PCT, the purpose is to correct testicular non-responsiveness or atrophy which has developed during a cycle. The longer the cycle, the more likely there will be a problem, and the worse the problem is likely to be.

When non-responsiveness occurs, then even after LH production is recovered the testes still do not produce testosterone in good amounts, and overall recovery is quite delayed. Losses from this steroid side effect can be severe.

A total HCG use of 5000-10,000 IU over a period of about 4-8 weeks can restore responsiveness.

It’s a poor and unnecessary plan to allow the testes to atrophy by starting HCG after the steroid cycle ends. It’s better to avoid atrophy and non-responsiveness from occurring in the first place. Further, HCG use during post-cycle therapy can impair recovery of LH production. So it’s not at all the ideal time to use it.


Instead, HCG should be used in the middle or late part of the cycle, and no later than the last steroid injection of the cycle.

The period of HCG use will typically be about 4 weeks. In an 8-12 week cycle, the 4 weeks (approximately) of use would be immediately prior to the last steroid injection. In a 14 week cycle, the about 4-week period should be in the late-middle part of the cycle. Examples would be using HCG in weeks 6-9, in weeks 9-12, or anywhere in-between.

The dosing is divided into at least 3 times per week. For example, 275 IU 3x/week provides 5000 IU over four weeks. But dosing could be daily, every other day, or 4x/week, as examples. There is little or no practical difference in results among these different schedules. It’s a matter of personal preference. The total amount taken per week doesn’t need to be any exact figure. For example it also would be fine to take 500 IU three times per week or to take 200 IU daily. Taking more than 1250 IU per week result in a 5000 IU vial lasting less than four weeks. For example, at 500 IU 3x/week, a vial lasts just over 3 weeks. This is acceptably close to 4 weeks, and ordinarily with this schedule a single vial still suffices. Much higher dosing than this gives no further results per week, and gives less results per vial.

When HCG is used according to this method, the side effects of testicular atrophy and loss of responsiveness are avoided, and recovery is complete as soon as LH production is restored. There’s then no need for PCT use of HCG, and recovery is faster as a result.

It’s worth mentioning also that in some cases, it will be better to use HCG throughout the steroid cycle rather than using it for only a 4 week period. One case is where the cycle uses only non-aromatizable steroids, such as Masteron, Primobolan, trenbolone, Anadrol, or oxandrolone. Estradiol levels drop undesirably low during non-aromatizing cycles, because testosterone levels drop very low and estradiol is produced principally from testosterone. By maintaining normal testosterone levels, HCG used throughout the cycle will also maintain sufficient estradiol levels.

Another case where it can be desirable to use HCG throughout the period of steroid use is where the user is not cycling at all, but using steroids chronically with no break.